Background Growth hormone (GH) has been proposed as an adjunct in in vitro fertilization
(IVF)/intracytoplasmic sperm injection (ICSI) cycles, especially in women with poor ovarian …

Background Patients undergoing in vitro fertilisation (IVF) receive various adjuvant therapies
in order to enhance success rates, but the true benefit is actively debated. Growth hormone …

Objective To evaluate the effectiveness of growth hormone (GH) supplementation in
improving the in vitro fertilization (IVF) outcomes of poor responders. Design Systematic …

In a sequential crossover study of IVF conducted from 2002 to 2006, growth hormone (GH)
supplementation was assessed in poor-prognosis patients, categorized on the basis of past …

Objective To appraise the current randomized clinical trials (RCTs) for evidence of the
association of growth hormone (GH) with improved outcomes in infertile women with …

Poor ovarian response (POR) often means low success rates after in vitro fertilisation (IVF).
We aim to study the impact of a low-dose growth hormone (GH) supplementation in …

Objective To analyze the effects of growth hormone (GH) supplementation during IVF/ICSI-
ET in Chinese patients who had prior IVF cycle with poor response to gonadotropin (Gn) …

Purpose The aim of this meta-analysis was to evaluate the effect of growth hormone (GH)
supplementation in poor responders undergoing in vitro fertilization (IVF) or intracytoplasmic …

Growth hormone (GH) has been shown to improve implantation and live birth rates in
women of> 40 years of age treated by in vitro fertilization (IVF). This effect was initially …

Background Many studies have demonstrated the benefits of the addition of growth hormone
(GH) to the controlled ovarian stimulation protocol in vitro fertilization (IVF) cycles in poor …